baber/WOPTO huggingface dataset:
Patent DK-0402212-T3 (DK)
Inventor: MULLER RENE M
IPC: B32B17/10
Filed: 1990-06-01
Granted: 1994-11-14
Abstract: Process for the manufacture of a coating layer made of heat-curable polyurethane having self-healing properties. 
<??>According to the invention the isocyanate component is essentially a diisocyanate or a mixture of diisocyanates in the form of monomers capable of forming an isocyanate trimer by a trimerisation reaction in the presence of a specific catalyst, the reaction mixture of the diisocyanate and of the polyol component, containing a trimerisation catalyst, is deposited by casting or spraying onto the support for forming the layer, and the trimerisation reaction is carried out on the said support, together with the polymerisation of the polyurethane layer under the effect of heat. 
<??>The coating layer is employed in safety glazing.
Patent DK-0426610-T3 (DK)
Inventor: SPECK ULRICH DR
IPC: A61K49/04
Filed: 1990-10-27
Granted: 1995-03-27
Abstract: N'-(2,3-Dihydroxy-N-methylpropyl)-N''-(2-hydroxyethyl)-5-hydroxy- acetamido-2,4,6-triiodoisophthalamide is outstandingly suitable as an X-ray contrast agent.
Patent DK-0462884-T3 (DK)
Inventor: VINCENT MICHEL
IPC: A61P25/28
Filed: 1991-06-18
Granted: 1993-08-23
Abstract: The invention relates to compounds of formula (I):   <IMAGE> (I)  in which: A represents, with the carbon and nitrogen atoms to which it is linked, cyclic amide as defined in the description, B represents, with the nitrogen and carbon atoms to which it is linked, saturated polycyclic structure as defined in the description, R represents hydrogen, optionally substituted lower alkyl, optionally substituted (4-imidazolyl)methyl, (3-pyrazolyl)methyl or optionally substituted (2-pyridyl)methyl, their enantiomers, diastereoisomers and epimers as well as their addition salts with a pharmaceutically acceptable acid. Medicinal products.
Patent DK-0548448-T3 (DK)
Inventor: OSHLACK BENJAMIN
IPC: A61K45/00
Filed: 1992-04-15
Granted: 2001-01-22
Abstract: A stabilized solid controlled release dosage form having a coating derived from an aqueous dispersion of ethylcellulose is obtained by overcoating a substrate including a therapeutically active with an aqueous dispersion of ethylcellulose and then curing the coated substrate at a temperature and relative humidity elevated to a suitable level above ambient conditions until the coated dosage form attains a stabilized dissolution profile substantially unaffected by exposure to storage conditions of elevated temperature and/or elevated relative humidity. <IMAGE>
Patent DK-0549067-T3 (DK)
Inventor: GREEFKES JOHANNES
IPC: C02F11/08
Filed: 1992-12-18
Granted: 1995-09-11
Abstract: In a continuous method for removal of dirt residues from metallic waste, particularly metallic waste occurring in household waste, the waste is rinsed with water, preferably in a two-stage rinsing drum (9). To avoid or reduce unwanted water outflows, and to make use of the removed dirt, the washing water carrying the removed dirt is subjected to an exothermal wet oxidation process at elevated temperature and pressure in a reactor (50) and then at least partly returned to the rinsing drum (9), via a sludge settling vessel (42). The heat produced in the wet oxidation can be used for example for heat exchange and for power generation. <IMAGE>
Patent DK-0549072-T3 (DK)
Inventor: BOSCH HENDRIK ADOLF
IPC: H01H71/52
Filed: 1992-12-18
Granted: 1995-11-27
Abstract: Electric circuit breaker or load switch, comprising a housing (21), at least one pair of contacts consisting of a fixed contact (23) and a movable contact (24) which can assume a first and second position relative to the fixed contact (23). A spring system, made up of a rigid arm (33) and a leaf spring (30), which leaf spring (30) is hinged by one end (32) to the arm (33), such that an arm-leaf spring assembly in the form of a toggle mechanism with a first (31) and second end (34) is formed. The first end (31) of this toggle mechanism is hinged to a movably supported element (25) having the movable contact (24), and the second end (34) is disposed hingedly supported at a distance from and opposite the fixed contact (23). Control means (37, 40) act upon the arm-leaf spring assembly for taking the contacts (23, 24) into the first and/or second position, in which the leaf spring (30) is released or tensioned, and latching means (45) are provided for locking the contacts (23, 24) in the first and/or second position. The rotatably disposed second end (34) of the arm-leaf spring assembly, the fixed contact (23) and the movable element (25) are positioned in such a manner relative to each other that the arm-leaf spring assembly both in the first and in the second position of the contacts (23, 24) assumes a relatively deflected position with respect to the situation in which the arm (33) and leaf spring (30) lie virtually in line with each other, with the result that the connection length of the switch is effectively reduced. <IMAGE>
Patent DK-0535192-T3 (DK)
Inventor: ARISAWA MIKIO
IPC: C07D291/08
Filed: 1992-04-09
Granted: 1996-08-05
Abstract: Compounds of the formula    <IMAGE>  II  in which P is hydroxy and T is the group -X2-CR7aR7b-CHR8-OH or T is hydrogen and P is the group O-CHR8-CR7aR7b-X2-OH and, wherein X1, X2, R1, R2, R3, R4, R5, R6, R7a, R7b, and R8 are as defined in the specification, or a reactive derivative thereof. These compounds are useful in the preparation of DNA gyrase inhibitors.
Patent DK-0678043-T3 (DK)
Inventor: FENTON PAUL V JR
IPC: A61M1/00
Filed: 1992-05-11
Granted: 1997-09-29
Abstract: A valved catheter is disclosed having an elongated, flexible tubular element defining a lumen extending along an axis substantially parallel to the central axis of the tubular element, and a bidirectional check valve assembly near its distal end which controls fluid flow in the tubular element. The valve assembly includes an aspiration valve offset from the tip of the distal end and an infusion valve formed at the tip of the distal end. The aspiration valve is generally defined by port(s) in the tubular element and a sleeve within the element underlying the ports, where the sleeve normally closes the ports. The aspiration valve permits fluid flow from the bloodstream into the element when the static fluid pressure inside the distal end is lower than the static fluid pressure outside the aspiration valve by an amount sufficient to displace the sleeve to allow fluid flow through the ports. The infusion valve includes a throat formed in the distal end which tapers down to a mouth formed by jaws at the tip. The mouth is essentially closed to fluid inflow from the patient into the tubular element and normally closed to fluid outflow from the tubular element into the patient. The infusion valve permits fluid infusion into the bloodstream when the static fluid pressure inside of the tubular element sidtal end is higher than the static fluid pressure outside of the infusion valve by an amount sufficient to force the mouth open. A bidirectionally valved multiple lumen catheter is also disclosed.
Patent DK-0598016-T3 (DK)
Inventor: KORENMAN ERNESTO MARCELO DARIO
IPC: G06F3/038
Filed: 1992-08-07
Granted: 1998-07-20
Abstract: The running of a program, designed to train the user to control one or more aspects of his or her psycho-physiological state, is controlled by signals representative of a psycho-physiological parameter of the user, e.g., galvanic skin resistance. This may be detected by a sensor unit with two contacts on adjacent fingers of a user. The sensor unit is separate from a receiver unit which is connected to a computer running the program.
Patent DK-0689497-T3 (DK)
Inventor: FELTON GEOFFREY
IPC: B26F1/14
Filed: 1992-11-13
Granted: 1999-09-20
Abstract: A punching device comprises a housing (6) carrying a main punch body (8) in the form of a plate mounted for rectilinear sliding movement, the punch body comprising a driving rack (10) extending downwardly along each side, and a plurality of integral punch members (12) projecting downwardly in a staggered array, said punch members being waisted (12d). The device comprises an operating handle (30) pivotally mounted on the housing (6) carrying drive pinions (32) engageable with the racks (10), so that by movement of the handle (30) the punch body may be raised and lowered. The punch body (8) additionally carries auxiliary punch members (12a), each being mounted on the punch body for longitudinal sliding movement relative thereto. Associated with each auxiliary punch member (12a) is a locking device (40), comprising a locking member (42) which is movable between an inoperative position in which the auxiliary punch member is capable of longitudinal sliding movement relative to the punch plate (8), and an operative position in which said auxiliary punch member moves with the punch body in a punching operation. In this way one or more of the auxiliary punch members (12a) may be taken out of operation to enable a stack of sheets of relatively small size to be provided with apertures along one side edge, or the auxiliary punch members may be brought into operation for the punching of apertures of a stack of sheets of full size. <IMAGE>
Patent DK-0609600-T3 (DK)
Inventor: SAMSON RICHARD D
IPC: B32B7/00
Filed: 1993-06-21
Granted: 2000-04-17
Abstract: An insect repellent fabric has a coating containing permethrin and a plasticizer, and a barrier covers the coating to protect the permethrin from degradation by ultraviolet light and oxygen. The barrier may be an acrylic coating or film, aluminum foil, a urethane coating or film, or an outer fabric barrier such as an awning or a tent fly. <IMAGE>
Patent DK-0587473-T3 (DK)
Inventor: BACHY ANDRE
IPC: C07D471/04
Filed: 1993-08-25
Granted: 1999-07-26
Abstract: Compounds of formula <IMAGE> in which R1 represents OH, (C1-C12)alkyl, (C1-C12)alkoxy, benzyloxy, benzyl, phenyl, (C1-C4)alkylNZ1Z2 or NZ1Z2; R2 represents OH, SH, (C1-C4)alkoxy, (C1-C4)alkylthio or NZ1Z2; R3 represents H, (C 1-C4)alkyl, (C1-C4)alkylthio, (C1-C4)alkoxy, phenyl or benzyl; A represents S, and in this case R does not represent anything, or A represents N and R represents H or (C1-C4)alkyl which can be substituted by phenyl or NZ1Z2; B represents a phenyl, pyridyl or thienyl ring which is condensed with the pyridyl ring and B is optionally substituted by one or more groups chosen from halo, (C1-C6)alkyl, (C1-C6)alkoxy, CF3, CH2NZ1Z2 or NZ1Z2; and Z1 and Z2 represent, independently of each other, H, (C1-C6)alkyl, formyl or benzyl or they form, with the nitrogen atom to which they are attached, an optionally substituted saturated heterocycle, it being understood that when A is S, R does not represent anything, R1 is -OCH3, R3 is H and B is thienyl, R2 cannot represent -OH or -OCH3; and their salts, which can be used as medicaments.
Patent DK-0620959-T3 (DK)
Inventor: DAVIDOV MIRCHO A
IPC: H04B7/26
Filed: 1993-01-08
Granted: 2003-12-08
Abstract: A bidirectional radio system for low cost, high through-put accumulation of data from a large number of site units. The site units are connected to remote radio transceivers in radio communication with a plurality of base stations. Accurate frequency synchronization allows multiple carriers within a 12.5 kHz FCC bandwidth. Frequency synchronization is achieved at low cost by transmitting a high accuracy carrier and clock signal at a base station, and using receiving circuitry a remote stations to extract the base clock signal and base carrier frequency and a phase-lock loop to stabilize the remote station carriers. The reception circuitry at a remote station provides independent carrier frequency and clock rate recovery, a phase-lock loop at baseband, and a coarse clock rate recovery circuit coupled to a fine clock rate recovery circuit. Remote station responses are time domain multiplexed. A base station receiver can decode a very short remote station response by scaling the response with the phase and amplitude of an initial segment of the response. Spatial reuse of carrier frequencies further increases the rate of data through-put.
Patent DK-0626001-T3 (DK)
Inventor: REITER UDO
IPC: C08G59/18
Filed: 1993-02-03
Granted: 1996-08-12
Abstract: PCT No. PCT/EP93/00243 Sec. 371 Date Aug. 10, 1994 Sec. 102(e) Date Aug. 10, 1994 PCT Filed Feb. 3, 1993 PCT Pub. No. WO93/16141 PCT Pub. Date Aug. 19, 1993The present invention relates to a powder coating, in particular for internal coating of packaging containers, which is characterized in that it 1.) comprises at least one epoxy resin having an epoxide equivalent weight of from 300 to 5500 and at least one hardener having more than one phenolic hydroxyl group per molecule and a hydroxyl equivalent weight, based on the phenolic OH groups, of from 100 to 500, and 2.) has a particle size distribution such that at least 90 percent by weight of the powder coating particles have a particle size of between 1 and 60  mu m, the maximum particle size of the powder coating particles is </=100  mu m, the mean particle size of the powder coating particles is between 5 and 20  mu m and the gradient of the particle distribution curve at the point of inflexion is >/=100.
Patent DK-0666912-T3 (DK)
Inventor: PANAYOTATOS NIKOS
IPC: A61P25/28
Filed: 1993-10-08
Granted: 1997-09-29
Abstract: Modified ciliary neurotrophic factors and methods for their production and therapeutic use. Also described is a method of screening for novel therapeutic proteins by determining altered electrophoretic binding properties.
Patent DK-0629701-T3 (DK)
Inventor: HANSON RONALD L
IPC: C12R1/01
Filed: 1994-06-10
Granted: 2000-04-17
Abstract: An enzymatic hydrolysis method, wherein one or more C-10 acyloxy-bearing taxanes are contacted with an enzyme or microorganism capable of hydrolyzing said acyloxy groups to hydroxyl groups. Also provided is an enzymatic esterification method, wherein one or more C-10 hydroxyl-bearing taxanes are contacted with an acylating agent and an enzyme or microorganism capable of esterifying said hydroxyl groups to form acyloxy groups. Further provided is an enzymatic hydrolysis method, wherein one or more C-13 acyloxy-bearing taxanes are contacted with an enzyme or microorganism capable of hydrolyzing said acyloxy groups to hydroxyl groups. The methods are especially useful for the preparation of compounds which may be employed as intermediates in the preparation of taxanes such as taxol.
Patent DK-0657431-T3 (DK)
Inventor: SCHMIDT BERNARD DR
IPC: C07D211/90
Filed: 1994-11-28
Granted: 2003-06-10
Abstract: 4-Phenyl 3-substituted 1,4-dihydropyridine esters are prepared by reacting benzaldehydes with keto esters and enamines, where appropriate with isolation of ylidene intermediates, or by esterification of corresponding dihydropyridinecarboxylic acids with alcohols. The 4-phenyl 3-substituted 1,4-dihydropyridine esters can be used as active ingredients in pharmaceuticals for the treatment of the central nervous system, in particular as cerebral therapeutic agents.
Patent DK-0660544-T3 (DK)
Inventor: CUTLER VICTOR HAWES JR
IPC: H04B7/212
Filed: 1994-12-01
Granted: 2003-06-30
Abstract: A communication system (10) communicates real time data through a channel (26) that imposes delays of variable duration on signals propagating therethrough. The channel (26) may be established between a fast-moving satellite (14) in an orbit (28) around the earth and a subscriber unit (24) located proximate the earth' surface. The real time data are generated synchronously (124) at the subscriber unit (24) with a TDM frame (40) established by the satellite (14). The data are delayed in a variable delay circuit (68) before transmission through the channel (26). The duration of the delay imposed by the delay circuit (68) varies in response to timing data received from the satellite (14). The timing data describe a changing propagation delay for the channel (26) and changing definitions for TDM time slots (42', 44'). Data received at the subscriber unit (24) are delayed in another variable delay circuit (76). Both gradual and abrupt timing characteristics of the channel (26) are absorbed by the variable timing circuits (68, 76). <IMAGE>
Patent DK-0773720-T3 (DK)
Inventor: LATORSE MARIE-PASCALE
IPC: A01N59/26
Filed: 1995-07-20
Granted: 2000-11-13
Abstract: A fungicidal composition comprising a compound A having the formula:  wherein M is an oxygen or sulphur atom, n is 0 or 1, and Y is a fluorine or chlorine atom or a methyl radical; and at least one fungicidal compound B. A method for preventing or controlling phytopathogenic fungi on crops by applying, an effective and non-plant-poisonous amount of said compound on the exposed parts of the plants is also disclosed.
Patent DK-0839046-T3 (DK)
Inventor: BOE ALESSANDRA
IPC: A61P31/04
Filed: 1995-07-14
Granted: 2002-02-18
Abstract: The present invention relates to the use of a TNF Receptor together with a steroid hormone to produce a pharmaceutical composition for the treatment of lethal bacterial and viral infections as well as autoimmune and inflammatory diseases. It also relates to said pharmaceutical compositions for the simultaneous, separate or sequential use of its active ingredients for the above specified treatment. In particular, it relates to the use of TBP-1 together with dehydroepiandrosterone (DHEA) or its metabolites to produce a pharmaceutical composition for the treatment of septic shock.
Patent DK-0868399-T3 (DK)
Inventor: LEUTNER BERND
IPC: B01D3/14
Filed: 1996-12-20
Granted: 2002-10-07
Abstract: A process is disclosed for producing an aqueous solution of free hydroxylamine. A solution obtained by treating an hydroxylammonium salt with a base is treated with water or water vapour at a temperature >/= 80  DEG C, so as to separate the solution into an aqueous hydroxylamine fraction and a salt fraction. This process is soft and easy to implement on a large scale. The risk of decomposition is minimised because of the low thermal stresses, the low hydroxylamine concentration and the short dwelling time during implementation of the process.
Patent DK-0841314-T3 (DK)
Inventor: JANSEN MICHAEL
IPC: C07C29/17
Filed: 1997-11-11
Granted: 2003-06-10
Abstract: A method for the catalytic hydrogenation of an organic compound in a solvent using an amorphous metal alloy catalyst is carried out under near-critical or supercritical solvent conditions.
Patent DK-0846753-T3 (DK)
Inventor: GREINDL THOMAS DR
IPC: D06L3/02
Filed: 1994-06-07
Granted: 2002-11-04
Abstract: Use of glycine-N,N-diacetic acid derivs. of formula (I) is claimed as complex formers for alkaline earth or heavy metals. R = 1-20C alkyl, 2-20C alkenyl or -A.CH(COOM).N(CH2COOM)2; A = 1-12C alkylene or a chemical bond; M = H, alkali metal or opt. substd. ammonium. The use of ~a-alanine-N,N-diacetic acids as builders in textile-washing powders or as Ca sequestrants in oral hygiene compsns. is specifically excluded. Also claimed are 2-alkylglycine-N,N-diacetonitriles or 2-alkylglycinenitrile -N,N-diacetonitriles (where alkyl = 1-20C alkyl or 2-20 C alkenyl); and cpds. of formula (II). X = carboxylic acid or nitrile function. Cpds. of formula (I) are new except when R = 1-3C alkyl and A = chemical bond.
Patent DK-0818270-T3 (DK)
Inventor: OBRIST BASIL
IPC: B23Q16/08
Filed: 1997-06-02
Granted: 2002-01-21
Abstract: The tension device has a coupling element (1) facing the item being clamped and a locally fixed tension element. The coupling element has grooves (13) which for fine-centring and determining the position in the X and/or Y direction interact with centring pins on the tension element. The tension bolt required for mutual fixing of the two elements is mounted on the tension element. The coupling element has a support member (11) projecting over the fine centring parts in order to protect these parts. The inside of the support member corresponds to the outer contour of the locally fixed coupling element.
Patent DK-0906139-T3 (DK)
Inventor: THIBERG ROLF
IPC: A61N5/06
Filed: 1997-06-04
Granted: 2003-12-08
Abstract: Apparatus for external medical treatment with light. A light-emitting device is provided that is adapted to be held in close proximity to the body of an individual and that includes light-emitting diodes or corresponding elements that are adapted to emit monochromatic light of a first wavelength. The light emitting device is driven by a drive arrangement for causing the light-emitting device to emit the monochromatic light over a first predetermined time period in a first state, and thereafter emit selectively monochromatic light of a different wavelength than the first wavelength and over a second predetermined time period in a possible second state. The drive arrangement causes the light-emitting device to pulsate the emitted light in accordance with a predetermined pulse frequency or series of pulse frequencies over the respective time periods, and causes the light-emitting device to emit the pulsating light with a pulse length that lies within an interval of about 60% to about 90% of the time between respective start edges of two mutually sequential pulses.
Patent DK-0912733-T3 (DK)
Inventor: CHENG JILL
IPC: C07K7/06
Filed: 1997-05-22
Granted: 2006-08-21
Abstract: This invention concerns novel receptor protein tyrosine phosphatase polypeptides. Specifically, this invention concerns the novel receptor protein tyrosine phosphatase  lambda  which is related to the homotypically adhering receptor protein tyrosine phosphatases  kappa  and  mu . The invention further relates to analogs of these polypeptides in other mammals, functional derivatives thereof, antibodies which are capable of specifically binding to these polypeptides, nucleic acids encoding these polypeptides, vectors containing and capable of expressing such nucleic acid and recombinant host cells transformed with such nucleic acid. Methods for the recombinant production of these receptor protein tyrosine phosphatase polypeptides and assays for identifying agonists and antagonists of these polypeptides are also within the scope of the invention.
Patent DK-1121145-T3 (DK)
Inventor: HAVELUND SVEND
IPC: A61P3/10
Filed: 1999-10-15
Granted: 2002-08-12
Abstract: A stable, aqueous insulin formulation suitable for pulmonary delivery is disclosed. The formulation comprises human insulin or an analogue thereof, 2 to 5 Zn<2+> ions per six molecules of insulin, 3 to 18 phenolic molecules per six molecules of insulin, and menthol. The characteristic smell of menthol masks the presence of phenols in the formulation without affecting the chemical and physical stability of the formulation.
Patent ES-2282064-T3 (ES)
Title: Procedimiento de reconocimiento de fallos de combustion que empeoran los gases de escape y dañan el catalizador en motores de combustion.
Inventor: EBELING KARL-HEINZ
IPC: G01M15/10
Filed: 2000-02-14
Granted: 2007-10-16
Abstract: Procedimiento de reconocimiento de fallos de combustión que empeoran los gases de escape y dañan el catalizador en motores de combustión interna con una sonda lambda dispuesta detrás del catalizador, en el que se reconocen fallos de combustión mediante un análisis de los números de revoluciones del motor o mediante una captación de otro tipo de la inestabilidad de marcha del motor en al menos un cilindro del motor de combustión interna, caracterizado porque se capta la tensión de la sonda lambda con referencia al fallo de combustión reconocido y porque, en función de la tensión de la sonda, se deduce la naturaleza del fallo de combustión.